Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joanne Billings, MD
University of Minnesota
Principal Investigator - Paul Beringer, PharmD
University of Southern California
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Southern California
Los Angeles, California, United States
Paul Beringer, PharmDRecruiting - University of Minnesota - Cystic Fibrosis Center
Minneapolis, Minnesota, United States
Joanne Billings, MDRecruiting - University of Utah
Salt Lake City, Utah, United States
Dave Young, PharmDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2012
- Primary completion
- 30 Jun 2015
- Completion
- 30 Jun 2015
- Last update posted
- 9 Dec 2014
- Registered enrollment
- 150
- Registry id
- NCT01543620
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.